Interesting study on 5yr CV event risk in early #rheumatoidarthritis pts who received T2T mgt shows no difference in CVE risk in ERA grp vs control ERA cohort: > Longer remission = protective for CVE > ⬆ HAQ = predictive of CVE Tighter control, ⬇ CVEs @RheumNow #ACR21 abs0282 https://t.co/GG7HPvWd0r